GALECTIN THERAPEUTICS INC.

Codice
GALT
Risorse esterne
Opinione della community
Prezzo Variazione Volume
2.32 -6.45 €
(-73.55%)
428474
P/E Obiettivo ad 1anno
0 2.75 €

Compra - Vendi

0
Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Grafico

Altri utenti che hanno investito

Transations in last week
Buy: 6
Sell : 4

Gian Marco

Commenti


Notizie

Insider Trading Activity Galectin Therapeutics Inc (NASDAQ:GALT) – Director Bought 1000 shares of Stock - Market Exclusive

On 10/8/2012 Peter G Traber, CEO, bought 5,000 with an average share price of $2.07 per share and the total transaction amounting to $10,350.00. View SEC Filing; On 10/9/2012 Peter G Traber, CEO, bought 2,500 with an average share price of $2.00 per ...altro » Leggi

Analysts mean rating score stands at 2.50 while Galectin Therapeutics, Inc.'s (GALT) stock price is now at $2.34 ... - Hot Stocks Point

Galectin Therapeutics, Inc. (GALT)'s Stock Price Trading Update: Galectin Therapeutics, Inc. (GALT), a part of Healthcare sector and belongs to Drugs – Generic industry; ended its day with gain 0.86% and finalized at the price of $2.34. During its last ...altro » Leggi

Trading Views: Checking the Numbers for Galectin Therapeutics Inc (GALT) - Sherwood Daily

The Relative Strength Index (RSI) is a highly popular momentum indicator used for technical analysis. The RSI can help display whether the bulls or the bears are currently strongest in the market. The RSI may be used to help spot points of reversals ... Leggi

Most Sizzling Mover: Galectin Therapeutics, Inc.'s (GALT) along week Volatility value 15.22% and monthly figure 8.20% - WsNews 4investors

Galectin Therapeutics, Inc. (GALT) stock price escalated 0.86% to finalize at $2.34 throughout previous buying and selling session. A total of 0.16 million shares exchanged at hands and its average trading volume is standing at 0.56 million shares ...altro » Leggi

Galectin Therapeutics Incorporated (NASDAQ:GALT) on Focus After Report of More Shorts - Finance News Daily

The short interest to Galectin Therapeutics Incorporated's float is 8.42%. About 132,416 shares traded. Galectin Therapeutics Inc (NASDAQ:GALT) has risen 62.09% since May 23, 2016 and is uptrending. It has outperformed by 45.39% the S&P500. Galectin ... Leggi

Stock Volatility Risk Alert: Galectin Therapeutics Inc Realized Volatility Hits An Escalated Level - CML News

As a heads up, in the "Why This Matters" section at the end of this article on Galectin Therapeutics Inc (NASDAQ:GALT) , we're going to take a step back and show really clearly that there is actually a lot less "luck" in successful option trading than ... Leggi

Technical Update on Shares of Galectin Therapeutics, Inc. (NASDAQ:GALT) - Rives Journal

Many investors may develop trading strategies that include highly volatile stocks, while others may look to avoid high volatility at all costs. Galectin Therapeutics, Inc. (NASDAQ:GALT)'s 12 month volatility is currently 131.577400. 6 month volatility ...altro » Leggi

Successful Earnings Option Trading: Galectin Therapeutics Inc (NASDAQ:GALT) - CML News

As we look at Galectin Therapeutics Inc we note that a long put is one of the most common implementations of an option strategy, but the analysis completed when employing the long put often times lacks the necessary rigor especially surrounding earnings. Leggi

Earnings Yield in Focus For Galectin Therapeutics, Inc. (NasdaqCM:GALT) - Union Trade Journal

The ERP5 of Galectin Therapeutics, Inc. (NasdaqCM:GALT) is 16358. The lower the ERP5 rank, the more undervalued a company is thought to be. Looking further, the MF Rank (aka the Magic Formula) is a formula that pinpoints a valuable company trading ...altro » Leggi

Short Term Technical Outlook: Galectin Therapeutics, Inc. (GALT), MakeMyTrip Limited (MMYT) - Post Analyst

Galectin Therapeutics, Inc. (NASDAQ:GALT) traded at an unexpectedly high level on 05/17/2017 when the stock experienced a -16.91% loss to a closing price of $2.26. The company saw 0.79 million shares trade hands over the course of the day. Given that ... Leggi